Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 28,800 shares at $185.87 ($5.4M) on 2021-07-12, disclosed to the SEC on 2021-07-14.
Open-market sale of $5.4M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $185.07 | 5,755 | $1.1M | 19.8% |
| 2 | $185.07 | 5,755 | $1.1M | 19.8% |
| 3 | $185.87 | 4,400 | $818K | 15.2% |
| 4 | $187.31 | 3,933 | $737K | 13.7% |
| 5 | $187.31 | 3,933 | $737K | 13.7% |
| 6 | $188.32 | 1,512 |
| $285K |
| 5.3% |
| 7 | $188.32 | 1,512 | $285K | 5.3% |
| 8 | $189.36 | 500 | $95K | 1.8% |
| 9 | $190.86 | 600 | $115K | 2.1% |
| 10 | $190.86 | 600 | $115K | 2.1% |
| 11 | $191.60 | 300 | $57K | 1.1% |
| Total | $186.53 avg | 28,800 | $5.4M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |